Zivo Bioscience Stock Analysis

ZIVO -  USA Stock  

USD 4.35  0.09  2.03%

The latest price rise of Zivo Bioscience may raise some interest from institutional investors as it is trading at a share price of 4.35 on 65,698 in trading volume. The company directors and management may have good odds in positioning the company resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 90.34. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Zivo Bioscience partners.
Check out Your Current Watchlist.

Search Stock Analysis 

The Zivo Bioscience stock analysis report makes it easy to digest most publicly released information about Zivo Bioscience and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Zivo Bioscience stock analysis module also helps to analyze the Zivo Bioscience price relationship with some important fundamental indicators such as market cap and management efficiency.

Zivo Bioscience Stock Analysis Notes

The company recorded a loss per share of 1.71. Zivo Bioscience had not issued any dividends in recent years. The entity had a split on the 28th of May 2021. ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people. For more information please call Andrew Dahl at 248 452 9866 or visit http://www.zivobioscience.com.

Zivo Bioscience Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Zivo Bioscience's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Zivo Bioscience or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Zivo Bioscience is way too risky over 90 days horizon
Zivo Bioscience appears to be risky and price may revert if volatility continues
The company currently holds 5.5 M in liabilities. Zivo Bioscience has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due.
Net Loss for the year was (8.78 M) with profit before overhead, payroll, taxes, and interest of 20 K.
Zivo Bioscience currently holds about 231.94 K in cash with (2.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Latest headline from MacroaxisInsider: Purchase by Cornell Alison A of 15000 shares of Zivo Bioscience

Zivo Bioscience Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 46.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zivo Bioscience's market, we take the total number of its shares issued and multiply it by Zivo Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Zivo Bioscience management efficiency ratios could be used to measure how well zivo bioscience manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Zivo Bioscience maintains the Market Risk Adjusted Performance of 6.61, downside deviation of 7.61, and Mean Deviation of 51.0. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zivo Bioscience, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Zivo Bioscience, which can be compared to its rivals. Please check out Zivo Bioscience market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Zivo Bioscience is priced fairly, providing market reflects its latest price of 4.35 per share. Given that Zivo Bioscience has jensen alpha of 25.5, we strongly advise you to confirm Zivo Bioscience's prevalent market performance to make sure the company can sustain itself at a future point.

Zivo Bioscience Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of seventy-eight. The Exponential Moving Average is calculated by weighting recent values of Zivo Bioscience more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Zivo Bioscience Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zivo Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zivo Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zivo Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Zivo Bioscience Predictive Daily Indicators

Zivo Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zivo Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Zivo Bioscience Forecast Models

Zivo Bioscience time-series forecasting models is one of many Zivo Bioscience's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zivo Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Zivo Bioscience Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Zivo Bioscience stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zivo Bioscience shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Zivo Bioscience. By using and applying Zivo Bioscience Stock analysis, traders can create a robust methodology for identifying Zivo Bioscience entry and exit points for their positions.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Zivo Bioscience to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Valuation Now


Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module
Check out Your Current Watchlist. Note that the Zivo Bioscience information on this page should be used as a complementary analysis to other Zivo Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Zivo Bioscience Stock analysis

When running Zivo Bioscience stock analysis, check to measure Zivo Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zivo Bioscience is operating at the current time. Most of Zivo Bioscience's stock examination focuses on studying past and present price action to predict the probability of Zivo Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zivo Bioscience's price. Additionally, you may evaluate how the addition of Zivo Bioscience to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
The market value of Zivo Bioscience is measured differently than its book value, which is the value of Zivo Bioscience that is recorded on the company's balance sheet. Investors also form their own opinion of Zivo Bioscience stock's value that differs from its market value or its book value, called intrinsic value, which is Zivo Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zivo Bioscience's market value can be influenced by many factors that don't directly affect Zivo Bioscience underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zivo Bioscience's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Zivo Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zivo Bioscience's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.